84 participants
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2023-04-05
- Completion:
- 2027-03-06
Conditions
- Cytomegalovirus Infection
Interventions
- BIOLOGICAL
No Results Yet